MorphoSys starts dosing in Phase 1/2a cancer drug trial
The trial aims to investigate the safety and preliminary efficacy of MOR202 in patients with relapsed or refractory multiple myeloma. In the trial, the patients with relapsed or
The Liverpool School of Tropical Medicine (LSTM) in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.
PrimeMobile incorporates functionality accessed on handheld devices with Greenway’s single-database electronic health record (EHR), practice management and interoperability solution – PrimeSuite. PrimeMobile’s administrative and financial capabilities integrate charge
Magellan’s Medical Pharmacy Solutions program is operated by its specialty pharmaceutical division, Icore Healthcare. The accreditation provides assurance to patients, providers, purchasers, regulators and employers that the practices
Perampanel is an orally administered, highly selective non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptor antagonist discovered and being developed by Eisai. In Study 305, the response rates (defined as